Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
Dr. Harris joins the PanTheryx board of directors to advance digestive and immune health research and consumer awareness
PanTheryx, an inclusive digestive and immune health company, today announced the addition of N. Stuart Harris, MD, to its board of directors. Dr. Harris is head of the Massachusetts General Hospital (MGH) Department of Wilderness Medicine, which practices resource-limited medicine under strict conditions. As a board member of PanTheryx, Dr. Harris will work with the company’s executive team and scientific advisory board to advance research focused on probiotics and cow colostrum for digestive and immune health.
This press release contains multimedia. View the full press release here: https://www.businesswire.com/news/home/20210928005173/en/
Dr. Stuart Harris, head of the Wilderness Medicine Division at Massachusetts General Hospital (MGH), joins the PanTherx board of directors. (Photo: Business Wire)
“We are pleased, Dr. Harris to join PanTheryx’s Board of Directors as he brings a unique perspective on preventive health and wellness, ”said David Abramson, Executive Chairman of the PanTheryx Board of Directors. “Dr. Harris’ clinical and field research also has extensive experience working with diverse populations.
Dr. Harris brings over twenty years of experience in emergency medicine, clinical research, and the interaction between the environment and human health. Dr. Harris is a full-time attending physician in the emergency room at MGH, an associate professor of emergency medicine at Harvard Medical School, and a faculty member of the Arctic Initiative at the Belfer Center at Harvard Kennedy School of Government.
Dr. Harris graduated from the Harvard Affiliated Emergency Medicine Residency in 2003. His research focuses on the pathogenesis and treatment of altitude sickness and the relationship between climate change and human health. His research teams are active in the Himalayas, Kilimanjaro, the Andes, Alaska and far eastern Siberia and have been funded by the National Institutes of Health, the US DOD, MGH and HMS.
“As a wilderness medicine expert and emergency doctor, I have experienced the power of the right diet in order to optimally operate all body systems through the support of the microbiome,” commented Dr. Stuart Harris. “I am excited to serve on the PanTheryx board of directors to influence clinical nutritional research and underscore the importance of the digestive system to health and wellbeing.”
To learn more about PanTheryx, please visit www.pantheryx.com.
About PanTheryx
PanTheryx ™ is a nutrition and biotechnology company dedicated to the global commercialization of health and wellness solutions for the human and animal health market. From leading cutting edge research to providing world class ingredients to commercializing industry leading consumer brands, PanTheryx is committed to delivering revolutionary approaches to digestive, immune and microbiome health. As the world’s largest manufacturer of colostrum, PanTheryx offers its proprietary ColostrumOne ™ and La Belle® colostrum ingredients to its partners serving the global health market for humans and animals. In addition to the products that it develops with its partners, the PanTheryx portfolio of consumer brands includes TruBiotics®, Goodgut®, Life’s First Naturals ™ and DiaResQ®. To learn more about PanTheryx, its consumer brands and colostrum ingredients, please visit www.pantheryx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/2020928005173/en/
